Additionally, downregulated genes in SCLC included MHC-II antigen presentation-related genes, such as CD74, CTSS, CIITA, HLA-DRA, HLA-E, and HLA-DPB1, crucial for CD4+ T cell-dependent immune responses. The gene discussed is HLA-DRA; the disease is small cell lung carcinoma.